SCHEMBL7463369

SCHEMBL7463369

CCc1cc(C)ccn1.c1cc2cc-2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 1/20 0.43
SREBF2 Q12772 1/20 0.43
CYP2A6 P11509 1/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
UHRF1 Q96T88 1/20 0.42
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
CCR8 P51685 1/20 0.42
MAPK14 Q16539 4/20 0.40
NOS2 P35228 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM1A O60341 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
GABRG2 P18507 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12596 0.88
SCHEMBL31421768 0.88
SCHEMBL10272612 0.87 SREBF1 (0.49) SREBF1SREBF2CYP1A2POLBMAPK14
SCHEMBL27440094 0.86 UHRF1 (0.50) SREBF1SREBF2CYP1A2POLBUHRF1
Bromide SCHEMBL28271991 0.86 UHRF1 (0.50) SREBF1SREBF2CYP1A2POLBUHRF1
SCHEMBL31555358 0.78 CYP1A2 (0.52) SREBF1SREBF2CYP1A2POLBNOS2
SCHEMBL8257156 0.77 SREBF2 (0.48) SREBF1SREBF2CYP1A2POLB
SCHEMBL11176714 0.75 MAP4K4 (0.49) SREBF1SREBF2CYP1A2POLBMEN1
SCHEMBL11372896 0.75 SREBF2 (0.54) SREBF2CYP1A2POLB
SCHEMBL17826980 0.75 CNR2 (0.47) SREBF1SREBF2CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0770065-A1 TRI-SUBSTITUTED PHENYL DERIVATES USEFUL AS PDE IV INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1997-05-02 EP disclosed
WO-1995035281-A1 TRI-SUBSTITUTED PHENYL DERIVATES USEFUL AS PDE IV INHIBITORS CELLTECH THERAPEUTICS LIMITED (GB) 1995-12-28 WO disclosed